Gabapentin

Product NDC
51224-219
11-digit product format
512240219
Labeler code
51224
Product ID
51224-219_7df72914-16b4-46c8-b04c-e68bdc664300
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Gabapentin
Dosage form
CAPSULE
Route
ORAL
Labeler
TAGI Pharma, Inc.
Application
ANDA075477
Marketing category
ANDA
Marketing start
2020-01-01
Marketing end
0000-00-00
Substance
GABAPENTIN
Active strength
400 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51224-219-50EA - Each51224-2199a2e6c63-2377-4fdb-9a5a-13797bcc8fdd12020-05-08
51224-219-60EA - Each51224-219383a4f17-6879-4579-b2de-52bf39260aec12020-05-08

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310432gabapentin 400 MG Oral CapsulePSN92c9d6ab-bed3-4eeb-9a6d-eb3af01335d01
310432gabapentin 400 MG Oral CapsuleSCD92c9d6ab-bed3-4eeb-9a6d-eb3af01335d01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51224-219-5051224021950100 CAPSULE in 1 BOTTLE (51224-219-50) 100 capsule2020-01-010000-00-00NoNoCurrent
51224-219-6051224021960500 CAPSULE in 1 BOTTLE (51224-219-60) 500 capsule2020-01-010000-00-00NoNoCurrent
51224-219-70512240219701000 CAPSULE in 1 BOTTLE (51224-219-70) 1000 capsule2020-01-010000-00-00NoNoCurrent